Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Scanderbeg

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
International Journal of Radiation Oncology, Biology, Physics|April 23, 2014
Direction-modulated brachytherapy for high-dose-rate treatment of cervical cancer. I: theoretical designDae Yup Han, Matthew J Webster, Daniel J Scanderbeg, et al.
Journal of Applied Clinical Medical Physics|June 29, 2025
AAPM medical physics practice guideline 13.a: HDR brachytherapy, part BSusan L Richardson, Arjit K Baghwala, Gil'ad N Cohen, et al.
Journal of Neuro-Oncology|May 16, 2013
Immediate post-operative brachytherapy prior to irradiation and temozolomide for newly diagnosed glioblastomaJ Dawn Waters, Brent Rose, David D Gonda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2012
Preferential replication of systemically delivered oncolytic vaccinia virus in focally irradiated glioma xenograftsSunil J Advani, Lisa Buckel, Nanhai G Chen, et al.
Journal of Applied Clinical Medical Physics|February 22, 2023
AAPM medical physics practice guideline 13.a: HDR brachytherapy, part ASusan L Richardson, Ivan M Buzurovic, Gil'ad N Cohen, et al.
Cancer Research|February 15, 2015
Tumor radiosensitization by monomethyl auristatin E: mechanism of action and targeted deliveryLisa Buckel, Elamprakash N Savariar, Jessica L Crisp, et al.
Molecular Cancer Therapeutics|October 11, 2019
Precision Chemoradiotherapy for HER2 Tumors Using Antibody Conjugates of an Auristatin Derivative with Reduced Cell PermeabilityDina V Hingorani, Matthew K Doan, Maria F Camargo, et al.
International Journal of Radiation Oncology, Biology, Physics|July 2, 2015
Clinical Outcomes of Computed Tomography-Based Volumetric Brachytherapy Planning for Cervical CancerDaniel R Simpson, Daniel J Scanderbeg, Ruben Carmona, et al.
Nature Communications|July 5, 2022
Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapyDina V Hingorani, Michael M Allevato, Maria F Camargo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 24, 2025
Interactions of Antibody Drug Conjugate Anti-Tubulin and Topoisomerase I Inhibitor Payloads with Radiotherapy to Potentiate ImmunotherapyJacqueline Lesperance, Bryan S Yung, Michael M Allevato, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
International Journal of Radiation Oncology, Biology, Physics|April 23, 2014
Direction-modulated brachytherapy for high-dose-rate treatment of cervical cancer. I: theoretical designDae Yup Han, Matthew J Webster, Daniel J Scanderbeg, et al.
Journal of Applied Clinical Medical Physics|June 29, 2025
AAPM medical physics practice guideline 13.a: HDR brachytherapy, part BSusan L Richardson, Arjit K Baghwala, Gil'ad N Cohen, et al.
Journal of Neuro-Oncology|May 16, 2013
Immediate post-operative brachytherapy prior to irradiation and temozolomide for newly diagnosed glioblastomaJ Dawn Waters, Brent Rose, David D Gonda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2012
Preferential replication of systemically delivered oncolytic vaccinia virus in focally irradiated glioma xenograftsSunil J Advani, Lisa Buckel, Nanhai G Chen, et al.
Journal of Applied Clinical Medical Physics|February 22, 2023
AAPM medical physics practice guideline 13.a: HDR brachytherapy, part ASusan L Richardson, Ivan M Buzurovic, Gil'ad N Cohen, et al.
Cancer Research|February 15, 2015
Tumor radiosensitization by monomethyl auristatin E: mechanism of action and targeted deliveryLisa Buckel, Elamprakash N Savariar, Jessica L Crisp, et al.
Molecular Cancer Therapeutics|October 11, 2019
Precision Chemoradiotherapy for HER2 Tumors Using Antibody Conjugates of an Auristatin Derivative with Reduced Cell PermeabilityDina V Hingorani, Matthew K Doan, Maria F Camargo, et al.
International Journal of Radiation Oncology, Biology, Physics|July 2, 2015
Clinical Outcomes of Computed Tomography-Based Volumetric Brachytherapy Planning for Cervical CancerDaniel R Simpson, Daniel J Scanderbeg, Ruben Carmona, et al.
Nature Communications|July 5, 2022
Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapyDina V Hingorani, Michael M Allevato, Maria F Camargo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 24, 2025
Interactions of Antibody Drug Conjugate Anti-Tubulin and Topoisomerase I Inhibitor Payloads with Radiotherapy to Potentiate ImmunotherapyJacqueline Lesperance, Bryan S Yung, Michael M Allevato, et al.
Pageof 2